Table S7. Immunohistochemical markers and gene rearrangements according to MYD88 variants. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Statistically significant differences (p<0.05) are indicated with an asterisk (*). Among ABC patients, MYD88 mutant patients are compared as a whole to MYD88 WT patients and MYD88 L265P mutant patients are compared to the remainder of ABC patients. Among GCB patients, MYD88 mutant patients are compared as a whole to MYD88 WT patients.